CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 700 of 749 entries

View as:

Neurohumoral Control of Intestinal Electrical and Mechanical Activity

Phase: N/A Priority: Normal

NCT ID: NCT00852553 Org: User:

Start: 02/28/03 End: 02/29/12 Due: 02/28/13

A Phone Intervention for Family Dementia Caregivers in Vietnam

Phase: N/A Priority: Normal

NCT ID: NCT05481320 Org: User:

Start: 10/27/22 End: 08/28/23 Due: 08/28/24

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal

NCT ID: NCT05843448 Org: User:

Start: 04/19/23 End: 12/31/26 Due: 12/31/27

Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department

Phase: N/A Priority: Normal

NCT ID: NCT06961058 Org: User:

Start: 06/15/25 End: 09/01/29 Due: 09/01/30

Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis

Phase: N/A Priority: Normal

NCT ID: NCT00826592 Org: User:

Start: 01/31/09 End: 08/31/09 Due: 08/31/10

Reducing Inappropriate Medication Use for BPSD

Phase: N/A Priority: Normal

NCT ID: NCT06040502 Org: User:

Start: 07/12/23 End: 05/30/24 Due: 05/30/25

External Fixation Versus Splinting of Acute Calcaneus Fractures

Phase: N/A Priority: Normal

NCT ID: NCT04063657 Org: User:

Start: 06/14/19 End: 09/03/19 Due: 09/03/20

Cosmetic Effects of Topical Acetyl Zingerone

Phase: N/A Priority: Normal

NCT ID: NCT03530787 Org: User:

Start: 12/11/17 End: 10/12/18 Due: 10/12/19

Blood Glycan Biomarkers in Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00897962 Org: User:

Start: 09/30/06 End: 01/12/16 Due: 01/12/17

Acceptability and Tolerance of a Protein and Micronutrient Fortified Food

Phase: N/A Priority: Normal

NCT ID: NCT03041103 Org: User:

Start: 01/31/17 End: 06/30/17 Due: 06/30/18

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

Phase: N/A Priority: Normal

NCT ID: NCT00386971 Org: User:

Start: 10/31/06 End: 12/31/09 Due: 12/31/10

Opioid Use in Shoulder Arthroplasty Patients: A Stratification and Algorithm

Phase: N/A Priority: Normal

NCT ID: NCT03808025 Org: User:

Start: 01/21/19 End: 05/04/23 Due: 05/04/24

A Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia

Phase: N/A Priority: Normal

NCT ID: NCT03549078 Org: User:

Start: 01/01/17 End: 08/14/19 Due: 08/14/20

Letrozole as a Treatment of Endometrial Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00997373 Org: User:

Start: 10/31/09 End: 09/30/13 Due: 09/30/14

Continuous Hemoglobin Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT01811342 Org: User:

Start: 11/30/12 End: 09/30/15 Due: 09/30/16

Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders

Phase: N/A Priority: Normal

NCT ID: NCT05390086 Org: User:

Start: 06/15/22 End: 08/26/22 Due: 08/26/23

Can Exposure to Inclusive Virtual Art Decrease Pain and Social Disconnection Among Individuals Living With Chronic Pain?

Phase: N/A Priority: Normal

NCT ID: NCT05310747 Org: User:

Start: 10/07/22 End: 01/06/23 Due: 01/06/24

Breastfeeding Education in the Time of COVID-19

Phase: N/A Priority: Normal

NCT ID: NCT04519216 Org: User:

Start: 07/31/20 End: 12/10/21 Due: 12/10/22

Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT00804310 Org: User:

Start: 08/31/09 End: 09/30/11 Due: 09/30/12

Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery

Phase: N/A Priority: Normal

NCT ID: NCT05215886 Org: User:

Start: 01/01/22 End: 12/31/28 Due: 12/31/29

Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00584675 Org: User:

Start: 02/28/07 End: 02/29/08 Due: 02/28/09

The Influence of Oral Probiotics on the Microbiome and Lipidome

Phase: N/A Priority: Normal

NCT ID: NCT03605108 Org: User:

Start: 06/29/18 End: 05/09/19 Due: 05/09/20

Characterization of the Melanoma-Specific Immune Response

Phase: N/A Priority: Normal

NCT ID: NCT00368615 Org: User:

Start: 08/31/07 End: 08/31/24 Due: 08/31/25

Online Network Intervention to Increase HIV Pre-exposure Prophylaxis Intention

Phase: N/A Priority: Normal

NCT ID: NCT04771312 Org: User:

Start: 07/19/21 End: 09/15/21 Due: 09/15/22

[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy

Phase: N/A Priority: Normal

NCT ID: NCT04186988 Org: User:

Start: 11/05/19 End: 03/12/20 Due: 03/12/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Neurohumoral Control of Intestinal Electrical and Mechanical Activity	NCT00852553	University of California, Davis	user2@example.com	None	2003-02-28	2012-02-29	2013-02-28	-	-	2025-07-14
A Phone Intervention for Family Dementia Caregivers in Vietnam	NCT05481320	University of California, Davis	user2@example.com	None	2022-10-27	2023-08-28	2024-08-28	-	-	2025-07-14
IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer	NCT05843448	University of California, Davis	user2@example.com	None	2023-04-19	2026-12-31	2027-12-31	-	-	2025-07-14
Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department	NCT06961058	University of California, Davis	user2@example.com	None	2025-06-15	2029-09-01	2030-09-01	-	-	2025-07-14
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis	NCT00826592	University of California, Davis	user2@example.com	None	2009-01-31	2009-08-31	2010-08-31	-	-	2025-07-14
Reducing Inappropriate Medication Use for BPSD	NCT06040502	University of California, Davis	user2@example.com	None	2023-07-12	2024-05-30	2025-05-30	-	-	2025-07-14
External Fixation Versus Splinting of Acute Calcaneus Fractures	NCT04063657	University of California, Davis	user2@example.com	None	2019-06-14	2019-09-03	2020-09-03	-	-	2025-07-14
Cosmetic Effects of Topical Acetyl Zingerone	NCT03530787	University of California, Davis	user2@example.com	None	2017-12-11	2018-10-12	2019-10-12	-	-	2025-07-14
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer	NCT00897962	University of California, Davis	user2@example.com	None	2006-09-30	2016-01-12	2017-01-12	-	-	2025-07-14
Acceptability and Tolerance of a Protein and Micronutrient Fortified Food	NCT03041103	University of California, Davis	user2@example.com	None	2017-01-31	2017-06-30	2018-06-30	-	-	2025-07-14
Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART	NCT00386971	University of California, Davis	user2@example.com	None	2006-10-31	2009-12-31	2010-12-31	-	-	2025-07-14
Opioid Use in Shoulder Arthroplasty Patients: A Stratification and Algorithm	NCT03808025	University of California, Davis	user2@example.com	None	2019-01-21	2023-05-04	2024-05-04	-	-	2025-07-14
A Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia	NCT03549078	University of California, Davis	user2@example.com	None	2017-01-01	2019-08-14	2020-08-14	-	-	2025-07-14
Letrozole as a Treatment of Endometrial Cancer	NCT00997373	University of California, Davis	user2@example.com	None	2009-10-31	2013-09-30	2014-09-30	-	-	2025-07-14
Continuous Hemoglobin Evaluation	NCT01811342	University of California, Davis	user2@example.com	None	2012-11-30	2015-09-30	2016-09-30	-	-	2025-07-14
Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders	NCT05390086	University of California, Davis	user2@example.com	None	2022-06-15	2022-08-26	2023-08-26	-	-	2025-07-14
Can Exposure to Inclusive Virtual Art Decrease Pain and Social Disconnection Among Individuals Living With Chronic Pain?	NCT05310747	University of California, Davis	user2@example.com	None	2022-10-07	2023-01-06	2024-01-06	-	-	2025-07-14
Breastfeeding Education in the Time of COVID-19	NCT04519216	University of California, Davis	user2@example.com	None	2020-07-31	2021-12-10	2022-12-10	-	-	2025-07-14
Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors	NCT00804310	University of California, Davis	user2@example.com	None	2009-08-31	2011-09-30	2012-09-30	-	-	2025-07-14
Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery	NCT05215886	University of California, Davis	user2@example.com	None	2022-01-01	2028-12-31	2029-12-31	-	-	2025-07-14
Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers	NCT00584675	University of California, Davis	user2@example.com	None	2007-02-28	2008-02-29	2009-02-28	-	-	2025-07-14
The Influence of Oral Probiotics on the Microbiome and Lipidome	NCT03605108	University of California, Davis	user2@example.com	None	2018-06-29	2019-05-09	2020-05-09	-	-	2025-07-14
Characterization of the Melanoma-Specific Immune Response	NCT00368615	University of California, Davis	user2@example.com	None	2007-08-31	2024-08-31	2025-08-31	-	-	2025-07-14
Online Network Intervention to Increase HIV Pre-exposure Prophylaxis Intention	NCT04771312	University of California, Davis	user2@example.com	None	2021-07-19	2021-09-15	2022-09-15	-	-	2025-07-14
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy	NCT04186988	University of California, Davis	user2@example.com	None	2019-11-05	2020-03-12	2021-03-12	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance